Page last updated: 2024-11-06

c.i. solvent orange 60

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID81344
SCHEMBL ID987493
MeSH IDM0353464

Synonyms (34)

Synonym
6925-69-5
12h-phthaloperin-12-one
solvent orange 60
unii-9p2zlv19f4
9p2zlv19f4 ,
c.i. solvent orange 78
c.i. disperse orange 24
einecs 230-049-5
solvaperm orange 3g
ec 230-049-5
c.i. solvent orange 60
EU-0053086
STK378023
12h-isoindolo[2,1-a]perimidin-12-one
12-phthaloperinone
AH-034/12055191
AKOS001725072
c.i. 564100
macrolex orange 3g
10h-perimidino(2,1-a)isoindol-10-one
61969-47-9
aminoplast orange lfp
sandoplast orange 3g
DTXSID4064507
SCHEMBL987493
W-110185
sr-01000536789
SR-01000536789-1
2,11-diazapentacyclo[10.7.1.02,10.04,9.016,20]icosa-1(19),4,6,8,10,12,14,16(20),17-nonaen-3-one
AS-17203
Q27272850
A923320
mfcd01791730
transparentorange3g
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.72 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (40.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]